James Yan
Chief Tech/Sci/R&D Officer chez ZAI LAB LIMITED
Postes actifs de James Yan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZAI LAB LIMITED | Chief Tech/Sci/R&D Officer | 01/04/2020 | - |
| Chinese Society of Toxicology | Corporate Officer/Principal | - | - |
Historique de carrière de James Yan
Anciens postes connus de James Yan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Formation de James Yan
| Peking Union Medical College | Doctorate Degree |
Statistiques
Internationale
| Chine | 4 |
| Îles Cayman | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
| Chinese Society of Toxicology |
